The role of endogenous ancestral nucleotide sequences in health and disease

Viruses have been suspected of contributing to the development of neurodegenerative diseases such as Parkinson’s, Alzheimer’s, multiple sclerosis and dementia. Their interaction with specific regions of the genome has shown to result in disease activation. These viruses shift the paradigm as they are not external invaders, but rather a natural part of our genetic makeup, passed down over generations known as endogenous ancestral nucleotide sequences (EANS).

This has ignited FBB Biomed’s focus towards an RNA sequencing-machine learning approach to monitor the activation of EANS in individuals with specific neurodegenerative diseases. This breakthrough allows for high level diagnostic precision in support of targeted treatment development strategies.

Join Dr. Howard Urnovitz, CEO of FBB Biomed, as he discusses hot topics including artificial intelligence (AI), emerging research of virology behaviors and the therapeutic challenges faced in viral-genomic interaction. FBB Biomed’s aim is to allow researchers to focus on disease specific areas of DNA, to shed light on targets for pharmaceutical progression.

Key learning objectives

• Explore the role of viral-genomic interactions in health and disease
• Understand the concept that viruses interact with the host genome, rather than acting in isolation
• Explore emerging research and its implications for understanding viral behavior and treatment strategies

Who should attend?

Public health administrators, molecular biologists, virologists, and medical researchers

Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.

Please find further information on LGC's Molecular Diagnostics equipment here.